Aspen Neuroscience (ASPE) IPO deck
Aspen Neuroscience is a clinical-stage regenerative medicine company developing autologous iPSC-derived cell therapies to replace lost dopaminergic neurons in Parkinson's disease.
Aspen Neuroscience is a clinical-stage regenerative medicine company developing autologous iPSC-derived cell therapies to replace lost dopaminergic neurons in Parkinson's disease.
%20IPO%20deck){kind=link}